Rare diseases
Investigational molecules
Locations
Study Comparing Ripretinib and Sunitinib for Patients with Advanced Gastrointestinal Stromal Tumors Previously Treated with Imatinib
FranceStudy of Elranatamab for Patients with Multiple Myeloma Resistant to Proteasome Inhibitors, Immunomodulatory Drugs, and Anti-CD38 Antibodies
BelgiumStudy Comparing Avelumab, Cetuximab, and Radiotherapy with Standard Treatments for Patients with Advanced Head and Neck Squamous Cell Carcinoma
FranceStudy on the Effects of Dapagliflozin on Blood Vessel Health in Patients with Chronic Kidney Disease
FranceStudy of Nemvaleukin Alfa and Pembrolizumab for Patients with Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.
AustriaStudy on Elranatamab and Daratumumab for Patients with Relapsed or Refractory Multiple Myeloma After Prior Treatment
AustriaStudy Comparing DTG/3TC and BIC/FTC/TAF for Maintaining HIV Control in Adults
SpainStudy Comparing Infliximab Alone or with Immunosuppressive Drugs for Moderate to Severe Crohn's Disease Patients
The NetherlandsStudy Comparing BI 907828 and Doxorubicin for Patients with Advanced Dedifferentiated Liposarcoma
BelgiumStudy of SY-1425 (tamibarotene) alone or with azacitidine in adult patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
FranceStudy on Preventing Post-Operative Atrial Fibrillation with Botulinum Toxin Injections in Patients Undergoing Cardiac Surgery
FranceStudy on the Safety and Imaging of Risankizumab-800CW for Patients with Inflammatory Bowel Disease
The NetherlandsTell us about your condition – we search every trial in Europe and connect you with the right site.
